Testing effectiveness (Phase 2)Study completedNCT00964002What this trial is testingEfavirenz in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer Institut Bergonié 61
Testing effectiveness (Phase 2)Study completedNCT00035113What this trial is testingEPO906 Therapy in Patients With Prostate CancerWho this might be right forProstatic Neoplasms Novartis Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT00480090What this trial is testingA Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate CancerWho this might be right forProstate Cancer University Health Network, Toronto 10
Testing effectiveness (Phase 2)Study completedNCT00068731What this trial is testingLycopene in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Study completedNCT00574769What this trial is testingSafety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerWho this might be right forProstate Cancer University of Southern California 27
Testing effectiveness (Phase 2)Study completedNCT00350051What this trial is testingZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate CancerWho this might be right forProstate Cancer Bayer 53
Early research (Phase 1)Study completedNCT00052000What this trial is testingA Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate CancerWho this might be right forProstate Cancer Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00307294What this trial is testingThalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)Who this might be right forProstate Cancer University of Pittsburgh 40
Early research (Phase 1)Study completedNCT03551782What this trial is testingCetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate CancerWho this might be right forCastration-Resistant Prostatic Neoplasms Janssen Research & Development, LLC 33
Testing effectiveness (Phase 2)Study completedNCT00020046What this trial is testingDocetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerWho this might be right forStage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00038246What this trial is testingStudy of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate CarcinomaWho this might be right forProstate Cancer M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00715078What this trial is testingTo Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) AntigenWho this might be right forProstate Cancer Dendreon 122
Testing effectiveness (Phase 2)Study completedNCT00078585What this trial is testingPROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyWho this might be right forProstate Cancer Bavarian Nordic 120
Testing effectiveness (Phase 2)Ended earlyNCT00638378What this trial is testingStudy of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate CancerWho this might be right forProstate Cancer Incyte Corporation 22
Testing effectiveness (Phase 2)Study completedNCT00140478What this trial is testingMifepristone (RU-486) in Androgen Independent Prostate CancerWho this might be right forProstate CancerAdenocarcinoma of Prostate Dana-Farber Cancer Institute 48
Not applicableEnded earlyNCT02055846What this trial is testingAnalysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate CancerWho this might be right forAndrogen-independent Prostate Cancer Institut Paoli-Calmettes 59
Testing effectiveness (Phase 2)Study completedNCT00520481What this trial is testingStudy With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate CancerWho this might be right forAdenocarcinoma of the Prostate Eli Lilly and Company 41
Testing effectiveness (Phase 2)Study completedNCT00181558What this trial is testingAtrasentan and Zometa for Men With Prostate Cancer Metastatic to BoneWho this might be right forProstate CancerAdenocarcinoma of the Prostate Massachusetts General Hospital 44
Testing effectiveness (Phase 2)Study completedNCT01656304What this trial is testingBevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone TherapyWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more Barbara Ann Karmanos Cancer Institute 16
Large-scale testing (Phase 3)Ended earlyNCT00024167What this trial is testingChemotherapy With or Without Strontium-89 in Treating Patients With Prostate CancerWho this might be right forProstate Cancer M.D. Anderson Cancer Center 265